Mielcarek, Marco <br/><br/>
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.  [electronic resource] 

 -  Blood  Jul 2003 
 - 756-62 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2002-08-2628  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Bone Marrow Transplantation--adverse effects<br/>Busulfan<br/>Cause of Death<br/>Cyclosporine--therapeutic use<br/>Female<br/>Graft vs Host Disease--epidemiology<br/>Hematologic Neoplasms--therapy<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Incidence<br/>Intestines--pathology<br/>Life Tables<br/>Liver--pathology<br/>Male<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Mycophenolic Acid--analogs & derivatives<br/>Organ Specificity<br/>Peripheral Blood Stem Cell Transplantation--adverse effects<br/>Retrospective Studies<br/>Severity of Illness Index<br/>Skin--pathology<br/>Survival Analysis<br/>Time Factors<br/>Tissue Donors<br/>Transplantation Conditioning<br/>Vidarabine--analogs & derivatives<br/>Washington--epidemiology<br/>Whole-Body Irradiation